Celox is a haemostatic agent, which means it is used to stop bleeding - widely used by the military and also found in the pre-hospital, hospital and workplace environments.
It is rapid acting - proven to stop otherwise lethal femoral artery bleeding in just a few minutes with compression treatment and is also very effective for venous and minor bleeding.
Celox was launched in 2006 and is available as a range of products - applicator, granules and pre-impregnated dressings.
Celox is made from chitosan granules - a natural polymer extracted from shrimp and crab shells.
It is non-exothermic, meaning it does not give off heat.
It is suitable for the treatment of patients with bleeding who are taking anti-coagulant (e.g., Warfarin and Heparin) and anti-platelet (e.g., Aspirin and Clopidogrel) medicines as well as those with hypothermic blood (as low as 13oC).
Celox is non-allergenic and has been successfully tested on humans with known fish/shellfish allergies without reaction to the chitosan.
The chitosan granules work on contact with blood whereby they swell, form a gel and stick together to form a plug. This gel plug can later be easily removed as part of the hospital treatment.
The use of Celox does not trigger the normal clotting process as it only clots blood it comes into contact with.
Chitosan is naturally broken down and then converted into materials normally present in the body.